Boothbay Fund Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,395
| Closed | -$682K | – | 1634 |
|
|
2024
Q4 | $682K | Sell |
17,395
-12,750
| -42% | -$500K | 0.02% | 644 |
|
|
2024
Q3 | $1.19M | Hold |
30,145
| – | – | 0.03% | 576 |
|
|
2024
Q2 | $1.18M | Sell |
30,145
-216
| -0.7% | -$8.42K | 0.03% | 564 |
|
|
2024
Q1 | $1.31M | Sell |
30,361
-9,895
| -25% | -$426K | 0.03% | 556 |
|
|
2023
Q4 | $1.85M | Buy |
+40,256
| New | +$1.85M | 0.05% | 431 |
|
|
2023
Q3 | – | Sell |
-9,983
| Closed | -$384K | – | 1880 |
|
|
2023
Q2 | $384K | Sell |
9,983
-1,842
| -16% | -$70.9K | 0.01% | 1020 |
|
|
2023
Q1 | $423K | Hold |
11,825
| – | – | 0.01% | 1114 |
|
|
2022
Q4 | $466K | Hold |
11,825
| – | – | 0.01% | 1003 |
|
|
2022
Q3 | $427K | Sell |
11,825
-14,481
| -55% | -$523K | 0.01% | 1136 |
|
|
2022
Q2 | $800K | Buy |
26,306
+1,980
| +8% | +$60.2K | 0.02% | 816 |
|
|
2022
Q1 | $744K | Buy |
24,326
+5,950
| +32% | +$182K | 0.02% | 867 |
|
|
2021
Q4 | $574K | Sell |
18,376
-32,948
| -64% | -$1.03M | 0.01% | 826 |
|
|
2021
Q3 | $784K | Sell |
51,324
-44,433
| -46% | -$679K | 0.02% | 716 |
|
|
2021
Q2 | $1.78M | Buy |
95,757
+4,941
| +5% | +$92K | 0.06% | 362 |
|
|
2021
Q1 | $1.63M | Buy |
90,816
+48,303
| +114% | +$865K | 0.06% | 307 |
|
|
2020
Q4 | $654K | Buy |
42,513
+5,995
| +16% | +$92.2K | 0.02% | 535 |
|
|
2020
Q3 | $404K | Sell |
36,518
-8,167
| -18% | -$90.4K | 0.02% | 615 |
|
|
2020
Q2 | $560K | Sell |
44,685
-20,304
| -31% | -$254K | 0.04% | 456 |
|
|
2020
Q1 | $737K | Buy |
64,989
+13,982
| +27% | +$159K | 0.06% | 313 |
|
|
2019
Q4 | $669K | Hold |
51,007
| – | – | 0.06% | 351 |
|
|
2019
Q3 | $460K | Sell |
51,007
-765
| -1% | -$6.9K | 0.04% | 404 |
|
|
2019
Q2 | $510K | Sell |
51,772
-22,390
| -30% | -$221K | 0.05% | 325 |
|
|
2019
Q1 | $753K | Buy |
74,162
+39,480
| +114% | +$401K | 0.07% | 226 |
|
|
2018
Q4 | $219K | Buy |
34,682
+15,407
| +80% | +$97.3K | 0.03% | 395 |
|
|
2018
Q3 | $254K | Sell |
19,275
-16,044
| -45% | -$211K | 0.03% | 447 |
|
|
2018
Q2 | $325K | Buy |
+35,319
| New | +$325K | 0.03% | 340 |
|